
CergenX is a pioneering medical technology company dedicated to enhancing early detection of neurological conditions in newborns. Their flagship product utilizes advanced artificial intelligence to analyze neonatal brain scans, enabling healthcare professionals to identify potential issues promptly. This early intervention can significantly improve treatment outcomes and long-term health prospects for infants.